AzTrials
AzTrials

Post-traumatic Stress Disorder (PTSD)NCT07747415

PTSD Risk Prediction Model for EICU Survivors

An observational study of Post-traumatic Stress Disorder (PTSD), run by Sir Run Run Shaw Hospital at 1 site in China.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Brief Title: PTSD Risk Prediction Model for EICU Survivors Official Title: Development and Validation of a Risk Prediction Model for Post-Discharge Post-Traumatic Stress Disorder in Emergency Department-Admitted EICU Survivors Study Type: Observational Brief Summary: This study aims to develop and validate a risk… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Post-traumatic Stress Disorder (PTSD)
How many people
800 participants
Where
1 siteChina
Study dates
15 Aug 2026to 30 Jun 2027
How long will I take part?
1 Month
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Adult patients (≥18 years) admitted to the emergency department and subsequently transferred to the emergency intensive care unit (EICU) at Sir Run Run Shaw Hospital and other participating centers, who survive to EICU discharge and meet the study eligibility criteria.

Who may be able to join

  • Age ≥ 18 years
  • Admitted to the emergency department and subsequently transferred to the EICU at a participating center
  • Availability of emergency department-to-EICU clinical data suitable for model development
  • Proficient in the communication language, able to communicate normally, without cognitive impairment, dementia, or history of primary psychiatric disorders
  • Survive to EICU discharge
  • Glasgow Coma Scale (GCS) score ≥ 12 at EICU discharge or at follow-up
  • Willing to participate and able to provide informed consent (or consent obtained from a legally authorized representative or witness if the participant is unable to provide consent)

Who cannot join

  • Voluntary withdrawal by the participant
  • Severe dementia, persistent coma, chronic vegetative state, or severe aphasia that precludes completion of PTSD assessment
  • Inability to establish any form of follow-up after discharge
  • Death prior to ICU discharge
  • Vulnerable populations other than elderly/critically ill patients (e.g., those with psychiatric disorders, cognitive impairment, pregnant women, illiterate individuals)
  • Other conditions deemed by the investigator to be unsuitable for participation or unable to ensure follow-up quality

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site
  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

    Hangzhou, Zhejiang, 310016

    Lifeng Xing, +86 17816857285, 3416231@zju.edu.cn

Other trials in China

About this study

Official title: Development and Validation of a Risk Prediction Model for Post-Discharge Post-Traumatic Stress Disorder in EICU Survivors

Brief Title: PTSD Risk Prediction Model for EICU Survivors

Official Title: Development and Validation of a Risk Prediction Model for Post-Discharge Post-Traumatic Stress Disorder in Emergency Department-Admitted EICU Survivors

Read more

Study Type: Observational

Brief Summary: This study aims to develop and validate a risk prediction model for post-traumatic stress disorder (PTSD) at 1 month after hospital discharge in adult survivors of emergency intensive care unit (EICU) care. PTSD is a common and serious psychological condition that can occur after a life-threatening medical event. Many EICU survivors experience persistent stress responses, sleep problems, avoidance behaviors, and difficulty returning to normal life after leaving the hospital. This prospective observational cohort study will enroll approximately 800 adult patients who are admitted to the EICU through the emergency department at Sir Run Run Shaw Hospital and other participating centers. Participants will be followed up at 1 month after EICU discharge to complete the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5), a diagnostic interview for PTSD. Clinical data collected during the emergency department stay and EICU course-including vital signs, laboratory tests, treatments, and severity of illness-will be used to build statistical models to predict which patients are most likely to develop PTSD. The study does not involve any experimental treatments or additional procedures beyond routine clinical care. Results from this study may help healthcare providers identify high-risk patients early and provide timely psychological support and follow-up care.

Detailed Description: Background: Advances in critical care medicine have enabled an increasing number of emergency critical care patients to survive to ICU or hospital discharge. However, a substantial proportion of survivors experience persistent psychological sequelae, including post-traumatic stress disorder (PTSD), which significantly impairs quality of life. Patients admitted to the EICU via the emergency department are exposed to multiple stressors during the early phase-sudden life-threatening illness, pain, hypoxia, altered consciousness, mechanical ventilation, sedation, and separation from family-which may serve as important risk factors for subsequent PTSD. Objectives: To develop and validate a risk prediction model for predicting 1-month post-discharge PTSD in adult patients admitted to the EICU via the emergency department. Study Design: This is a prospective observational cohort study conducted at Sir Run Run Shaw Hospital, Zhejiang University School of Medicine (coordinating center) and multiple other centers. Study Population: Adult patients (≥18 years) admitted to the emergency department and subsequently transferred to the EICU, with an ICU length of stay of at least 24 hours, who survive to EICU discharge and have a Glasgow Coma Scale score ≥12 at discharge or follow-up. Sample Size: Approximately 800 patients (approximately 200 per center if 4 centers participate), calculated based on an estimated 25% PTSD prevalence at 1 month post-discharge, with 6-8 candidate predictors, expected Nagelkerke R² of 0.15, target shrinkage of 0.90, and accounting for 15%-20% attrition. Data Collection: All variables are routine clinical observation and laboratory parameters, categorized into six domains: (1) baseline susceptibility variables (demographics, social support, psychiatric history, trauma history, prior ICU admission, substance use, chronic disease burden); (2) emergency admission phase variables (mode of admission, severity, vital signs, etiology, early labs, emergency treatments); (3) first 24 hours in EICU variables (severity scores, organ support, sedation/analgesia, neurological status, nursing exposures, early complications); (4) cumulative EICU exposure variables (duration of organ support, cumulative sedation/analgesia, mechanical ventilation duration, physical restraints, delirium, infections, major complications); (5) disease process and treatment-related variables (severe infection, respiratory failure, AKI, ARDS, transfusion, emergency surgery, intubation, CPR); and (6) 1-month post-discharge follow-up (CAPS-5 diagnostic PTSD assessment). Primary Outcome Measure: CAPS-5-diagnosed PTSD at 1 month post-EICU discharge. Statistical Analysis: Three types of prediction models will be developed: (1) an early model using variables available within the first 6 hours from emergency department presentation to EICU admission; (2) a discharge-updated model adding ICU exposure, treatment interventions, complications, and pre-discharge information; and (3) a dynamic digital model further adding post-discharge electronic follow-up and digital phenotyping data. Candidate modeling approaches include logistic regression, LASSO/ElasticNet penalized regression, random forest, gradient boosting trees, XGBoost/LightGBM, and support vector machines. Model performance will be evaluated for di

Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07747415
Study groupRoleWhat they receive
EICU Survivor CohortThis is a single prospective observational cohort of adult patients admitted to the EICU via the emergency department. Participants are followed up at 1 month post-discharge for PTSD assessment using CAPS-5. No interventions are administered as part of this study.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. CAPS-5-Diagnosed PTSD at 1 Month Post-EICU Discharge

    Presence of post-traumatic stress disorder (PTSD) as diagnosed by the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5), a structured diagnostic interview administered by trained assessors, at 1 month following discharge from the emergency intensive care unit (EICU). The CAPS-5 yields both a dichotomous diagnosis (PTSD present/absent) and a continuous severity score.

    Measured: 1 month after EICU discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Aug 2026
  2. Study start15 Aug 2026 (estimated)
  3. Primary completion30 Mar 2027 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
800 participants (estimated)
Target duration
1 Month
IDs, dates and publications
ClinicalTrials.gov ID
NCT07747415
Sponsor's protocol ID
SRRSH-EC-2026-0681
Status last verified
Jul 2026
First submitted
31 Jul 2026
Last updated
5 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Post-traumatic Stress Disorder (PTSD), run by Sir Run Run Shaw Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 5 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lifeng Xing (+86 17816857285, 3416231@zju.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

CAPS-5-Diagnosed PTSD at 1 Month Post-EICU Discharge (time frame: 1 month after EICU discharge). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Aug 2026; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in